CD19 and congenital rubella syndrome: Hay et al. observed higher levels of von willebrand factor (VWF), a molecule secreted by endothelial cells upon activation, in CD19-targeting CAR-T cells treated patients’ serum cells with grade 4 ≥ CRS compared to patients with grade ≤ 3 CRS [148].